LATEST: As one of the nation’s leading academic and research health systems, we are committed to strengthening our community. We recognize the growing demand...
LATEST: It takes a whole village to estimate the impact of new energy sources and to collaborate to achieve carbon neutrality. GLOW offers an excellent...
LATEST: Receiving orphan drug designation for ISB 1442 is an important milestone on Ichnos’ journey to developing potentially curative therapies for patients...